Expanding the phenotypic spectrum of ARCN1-related syndrome
Alyssa L Ritter,Jessica Gold,Hiroshi Hayashi,Amanda M Ackermann,Stephanie Hanke,Cara Skraban,Sanmati Cuddapah,Elizabeth Bhoj,Dong Li,Yukiko Kuroda,Jessica Wen,Ryojun Takeda,Audrey Bibb,Salima El Chehadeh,Amélie Piton,Jeanine Ohl,Mary K Kukolich,Keisuke Nagasaki,Kohji Kato,Tomoo Ogi,Tricia Bhatti,Pierre Russo,Bryan Krock,Jill R Murrell,Jennifer A Sullivan,Vandana Shashi,Nicholas Stong,Hakon Hakonarson,Kentaro Sawano,Erin Torti,Rebecca Willaert,Yue Si,William Ross Wilcox,Katrine Verena Wirgenes,Kristian Thomassen,Katherine Carlotti,Angelika Erwin,Joanna Lazier,Thorsten Marquardt,Miao He,Andrew C Edmondson,Kosuke Izumi,Alyssa L. Ritter,Amanda M. Ackermann,Mary K. Kukolich,Jill R. Murrell,Jennifer A. Sullivan,Andrew C. Edmondson
DOI: https://doi.org/10.1016/j.gim.2022.02.005
IF: 8.864
2022-03-01
Genetics in Medicine
Abstract:PURPOSE: This study aimed to describe the phenotypic and molecular characteristics of ARCN1-related syndrome.METHODS: Patients with ARCN1 variants were identified, and clinician researchers were connected using GeneMatcher and physician referrals. Clinical histories were collected from each patient.RESULTS: In total, we identified 14 cases of ARCN1-related syndrome, (9 pediatrics, and 5 fetal cases from 3 families). The clinical features these newly identified cases were compared to 6 previously reported cases for a total of 20 cases. Intrauterine growth restriction, micrognathia, and short stature were present in all patients. Other common features included prematurity (11/15, 73.3%), developmental delay (10/14, 71.4%), genitourinary malformations in males (6/8, 75%), and microcephaly (12/15, 80%). Novel features of ARCN1-related syndrome included transient liver dysfunction and specific glycosylation abnormalities during illness, giant cell hepatitis, hepatoblastoma, cataracts, and lethal skeletal manifestations. Developmental delay was seen in 73% of patients, but only 3 patients had intellectual disability, which is less common than previously reported.CONCLUSION: ARCN1-related syndrome presents with a wide clinical spectrum ranging from a severe embryonic lethal syndrome to a mild syndrome with intrauterine growth restriction, micrognathia, and short stature without intellectual disability. Patients with ARCN1-related syndrome should be monitored for liver dysfunction during illness, cataracts, and hepatoblastoma. Additional research to further define the phenotypic spectrum and possible genotype-phenotype correlations are required.
genetics & heredity